Intel invests 5 billion euros in its facility in Ireland.

      Intel is investing 5 billion euros (approximately $5.7 billion) to enhance its Leixlip campus in Ireland, concentrating on Fab 34, which is among the limited EUV-capable facilities in Europe. This investment represents about 30% of Intel's projected $17 billion capital expenditure for 2026, with the majority being utilized by the end of 2027, and it is expected to add several hundred jobs to the current workforce of approximately 4,900 in Ireland. It’s important to note that the chips being developed are Xeon server CPUs, not AI accelerators, indicating that this move is more of an AI-adjacent strategy rather than a direct challenge to Nvidia.

      The investment targets data center processors for AI and high-performance computing, as reported by Bloomberg. The budget allocation is substantial and encompasses not just factory upgrades but also new equipment and an expanded automated track system to connect production modules.

      Fab 34, which began operations in 2023, is a key facility utilizing extreme ultraviolet lithography, essential for producing cutting-edge chips. Despite Europe being a leader in designing and manufacturing EUV machines through ASML, very few are operational in Europe itself. Currently, the campus manufactures Intel’s Xeon 6 processors and next-generation products.

      It’s essential to clarify that Xeon is classified as a server CPU, rather than an AI accelerator, meaning Intel is not directly competing with Nvidia's GPUs with this investment. Instead, Intel’s focus is on providing the host CPUs necessary for AI infrastructures, which is a substantial and expanding market.

      The company is currently in the midst of a turnaround, facing challenging financial circumstances. With annual capital spending on factories exceeding $20 billion, free cash flow remains significantly negative. The 18A process has reached high-volume manufacturing, and yields are improving; however, Intel has struggled to secure significant external customers and most of the consumption is from Intel itself and the US Department of Defense.

      Intel’s share price has significantly increased, outpacing its actual manufacturing performance. While discussions with Apple have positively influenced perceptions, it remains uncertain whether Apple truly seeks to partner with Intel as a second source.

      From a European perspective, an American company enhancing leading-edge capacities in Ireland presents a dual-edged situation. Although it represents increased capacity within Europe, it is still not under EU control. This creates a tension within the EU's strategy, especially with the EU Chips Act aiming to produce 20% of the world’s semiconductors by 2030—a target many analysts view as unachievable. Critics argue that achieving chip independence is unlikely and that supply chains of this nature cannot be localized easily.

      In response, the EU has shifted focus with a tech sovereignty package and an updated Chips Act that prioritizes stimulating demand rather than merely funding factories. Intel's investment fits into this discussion but does not resolve the complexities involved.

      The job growth and financial investment are tangible, and Ireland has benefited from collaboration with Intel, which has limited excess cash. The expansion of Fab 34 as a more significant EUV facility indeed bolsters Europe’s semiconductor capabilities. However, this expansion is focused on Intel’s own products rather than securing external clients for its manufacturing services. Until a significant external customer commits to purchasing in substantial volumes, such expansions rely on maintaining demand for Intel’s products, which currently appears favorable due to the ongoing AI boom, though this trend is not guaranteed to last.